Merck: This Cancer-Drug Powerhouse Could Be a Core Dividend
A dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
Explore essential resources for zero based budgeting to help you manage your finances better. Start planning your budget effectively.
19,172 articlesA dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
As the renewables wave grows, Clearway Energy (CWEN) stands out with a diversified solar and wind portfolio. This gui...
Two tech giants are racing to lead AI-enabled advertising, search, and social platforms. This article analyzes why Al...
A fresh take on dine brands (din) 2025, focusing on Q4 signals, brand momentum, and how investors can position themse...
As the SaaS crowd sinks, AI-powered software names may rise to the occasion in 2026. This article explains why and po...
OpenAI wins a Pentagon deal to deploy its AI in classified systems as Anthropic is designated a supply chain risk by ...
'scream 7' opened with a $64.1 million domestic debut, the year’s best start and a clear sign that millennial nostalg...
Rivian is set to unveil the R2 on March 12, a mass-market SUV that could determine the company’s profitability and st...
Broadcom is signaling strong momentum in AI infrastructure with a growing portfolio of custom chips and a robust back...
February layoffs slowed to 48,307, down sharply from January and far below last year's level. Analysts warn volatilit...
BitGo is lining up a $2 billion IPO and seeking an OCC national bank charter, while facing competition from Morgan St...
As Tehran grapples with itself, global markets price in oil volatility and currency risk. Analysts say Iran sends con...